Clinical Trial Update: Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing acute renal oxygenation and autonomic function effects of SGLT2 inhibition in type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Neuropathy Diabetic
• Diabetic Nephropathy
• Renal Hypoxia
• Type 1 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor (unspecified) (SGLT2 inhibitor)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Nephropathy, Hypoxia | Phase 4 | Status: COMPLETED